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ABSTRACT
Objective To investigate percutaneous coronary 
intervention (PCI) practice in an international cohort of 
patients with spontaneous coronary artery dissection 
(SCAD). To explore factors associated with complications 
and study angiographic and longer term outcomes.
Methods SCAD patients (n=215, 94% female) who 
underwent PCI from three national cohort studies were 
investigated and compared with a matched cohort of 
conservatively managed SCAD patients (n=221).
Results SCAD- PCI patients were high risk at 
presentation with only 8.8% undergoing PCI outside 
the context of ST- elevation myocardial infarction/cardiac 
arrest, thrombolysis in myocardial infarction (TIMI) 
0/1 flow or proximal dissections. PCI complications 
occurred in 38.6% (83/215), with 13.0% (28/215) 
serious complications. PCI- related complications were 
associated with more extensive dissections (multiple vs 
single American Heart Association coronary segments, 
OR 1.9 (95% CI: 1.06–3.39),p=0.030), more proximal 
dissections (proximal diameter per mm, OR 2.25 
(1.38–3.67), p=0.001) and dissections with no contrast 
penetration of the false lumen (Yip- Saw 2 versus 1, 
OR 2.89 (1.12–7.43), p=0.028). SCAD- PCI involved 
long lengths of stent (median 46mm, IQR: 29–61mm). 
Despite these risks, SCAD- PCI led to angiographic 
improvements in those with reduced TIMI flow in 84.3% 
(118/140). Worsening TIMI flow was only seen in 7.0% 
(15/215) of SCAD- PCI patients. Post- PCI major adverse 
cardiovascular and cerebrovascular events (MACCE) and 
left ventricular function outcomes were favourable.
Conclusion While a conservative approach to 
revascularisation is favoured, SCAD cases with higher 
risk presentations may require PCI. SCAD- PCI is 
associated with longer stent lengths and a higher risk 
of complications but leads to overall improvements 
in coronary flow and good medium- term outcomes in 
patients.
INTRODUCTION
Spontaneous coronary artery dissection (SCAD) is an 
important cause of acute coronary syndromes (ACS), 
predominantly affecting young to middle- aged 
women.1–3 Percutaneous coronary intervention (PCI) 
in acute SCAD has been associated with an increased 
risk of procedural complications compared with 
atherosclerotic ACS, with ‘PCI technical failure’ 
reported in 36%–53% of cases.4 5 Complications 
include iatrogenic dissection, haematoma exten-
sion and emergency coronary artery bypass grafting 
(CABG).4–6 When managed conservatively, most 
SCAD heals completely with restoration of apparently 
normal coronary architecture at follow- up.7 8 For this 
reason, the American and European Consensus State-
ments on SCAD both advocate conservative manage-
ment over PCI, where this is possible.1 2
Accepting that conservative management is 
favoured ‘where possible’, there remains a signif-
icant population of SCAD patients where conser-
vative management risks extensive infarction.9 10 
For these higher risk cases, it remains unclear to 
what extent complications are a necessary cost of 
improving coronary perfusion and if a more proac-
tive approach to revascularisation may be important 
for selected patient groups.
In this study, our objective was to investigate 
outcomes in a large observational SCAD- PCI cohort 
derived from three national registries. In particular, 
to investigate the balance of risks and benefits of 
PCI in a SCAD population.
METHODS
Study population
The study was conducted in accordance with the 
Declaration of Helsinki. Patients and the public 
(http:// beatscad. org. uk/) were involved in the 
funding, concept and dissemination of the study 
findings. Patients were recruited from the UK, 
Dutch and Spanish SCAD registries with SCAD 
events from 2003 to 2019. More details of these 
registries are provided in the online supplemental 
data. Patients in all studies gave written informed 
consent to data collection and contact for assess-
ment of outcomes.
Definition of PCI
PCI was defined by an apparent angiographic intent 
to intervene through, at minimum, the passage of a 
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coronary guidewire except where guidewire passage was solely 
for the purpose of diagnostic intracoronary imaging.
All SCAD patients with PCI were included. To fully charac-
terise SCAD in the PCI cohort, each national registry selected 
a matching number of consecutively recruited conservatively 
managed controls for comparison. As the aim was to investi-
gate the clinical and angiographic differences between PCI 
and conservative cohorts (rather than to investigate outcomes 
in patients with equivalent presentations), cases were selected 
blinded to clinical and angiographic findings and without prior 
matching for demographic or angiographic features. Any cases 
or controls not felt to be definite SCAD by any observer during 
the subsequent angiographic analysis were excluded. This small 
number of exclusions means the final analysed groups are of 
slightly different sizes. Iatrogenic dissection cases were only 
included if there was clear evidence of SCAD preceding and/
or anatomically remote from the iatrogenic injury. Iatrogenic 
dissections were further classified according to whether they 
occurred during the diagnostic or interventional phase of the 
procedure.
Confirmation of SCAD diagnosis
All patients had an angiographically confirmed diagnosis of 
SCAD on image review. All angiograms, with intracoronary 
imaging where available, were assessed by experienced inter-
ventional cardiologists representing at least two of the national 
registries with any initial disagreements resolved by consensus. 
Patients with atherosclerotic, traumatic or iatrogenic dissec-
tion (except where the latter complicated definite SCAD) were 
excluded.
Patient, SCAD and intervention characteristics
Demographic information, medical history and a detailed 
history of the SCAD event were obtained from the patient’s 
medical record. PCI procedure details were collected from 
procedure reports. Clinical characteristics included: myocar-
dial infarction type (cardiac arrest, non- ST- elevation myocar-
dial infarction (NSTEMI) or ST- elevation myocardial infarction 
(STEMI)) - STEMI was defined as typical ECG changes occur-
ring at any stage prior to angiography; cardiac arrest as any 
cessation of circulation requiring resuscitation occurring before 
the diagnostic angiographic procedure), pregnancy- associated 
SCAD (P- SCAD) as SCAD occurring during gestation or within 
12 months of delivery. Not all registries held the full contem-
poraneous medical records to allow an accurate determination 
of admission blood pressure to reliably determine cardiogenic 
shock according to accepted standard definitions. These data 
were therefore not included.
Angiographic analysis
Details of SCAD findings were recorded from angiographic 
images. Additionally, see online supplemental data.
Outcomes
PCI complications were recorded from angiographic images 
and defined as: aorto- ostial iatrogenic dissection; haematoma 
extension; loss of flow in the stented vessel or a significant side 
branch (>2 mm diameter); and vessel perforation as shown 
by extravasation of contrast (contrast penetration of the false 
lumen during PCI was not considered a complication). Serious 
PCI complications were defined as aorto- ostial iatrogenic dissec-
tion, complications resulting in reduced flow in a proximal 
epicardial coronary vessel or leading to unplanned left mainstem 
(LMS) stenting or CABG. There is no established definition of 
SCAD- PCI complications, although these are acknowledged to 
be somewhat different from those in atherosclerotic ACS. The 
interventional representatives of the three national registries 
therefore adopted these consensus definitions, largely based on 
those reported in related studies.1 2
Postoperative outcomes were major adverse cardiovascular 
and cerebrovascular events (MACCEs; death, stroke, myocar-
dial infarction or revascularisation occurring at any point after 
discharge from the index SCAD event) and recurrence (a new 
angiographically confirmed SCAD occurring after discharge 
from the index episode and either anatomically or temporally 
separated from the first event). Time to recurrence and time to 
MACCE were also recorded.
Statistical analysis
Patient, clinical and intervention characteristics were summarised 
by median and IQR for continuous measures or number and 
percentage for categorical variables. Comparisons of number 
and total length of stents between SCAD- PCI patients who 
developed complications and uncomplicated SCAD- PCI patients 
were made using Kruskal- Wallis test as the variables were not 
normally distributed.
Logistic regression was used to calculate the OR and 95% 
CIs of the risk of any complication and serious complications 
associated with patient, clinical and intervention characteris-
tics. Unadjusted and two adjusted models were created. The 
first adjusted model included age, sex and ethnicity. The second 
adjusted model included additionally all patient, clinical and 
intervention characteristics significantly associated with the 
outcome of interest. The latter was performed to assess which of 
the characteristics remained significant when all variables were 
adjusted for (eg, total stent length and number of stents). Due 
to the inclusion of variables pertaining to stents, only stented 
individuals were included in the analyses. An a priori decision 
was made that interaction terms would not be included, as we 
did not believe that the joint effect of any two of these variables 
would be higher than expected from the sum of their individual 
effects.
Two Kaplan- Meier plots were constructed to compare: (1) 
time to MACCE and (2) time to recurrence for SCAD- PCI and 
SCAD- non- PCI patients. As the proportional hazards assump-
tion was met, as assessed by Kaplan- Meier plot and the test of 
Grambsch- Therneau,11 Cox proportional hazards regression 
models were used to calculate the HR and 95% CI for the risk 
of MACCE and recurrence associated with patient, clinical 
and intervention characteristics, with adjustment for age, sex 
and ethnicity. To assess differences in risk between SCAD- PCI 
and SCAD- non- PCI patients, an interaction term between clin-
ical management (PCI vs conservative) and the predictor was 
included.
All statistical analyses were performed using STATA release 




Two hundred and fifteen SCAD- PCI patients were included. 
Patient, clinical and intervention characteristics are summarised 
in table 1. Patients were predominantly female and white Euro-
pean with a median age at the time of SCAD of 48 years. In the 
SCAD PCI cohort there were 12 (5.6%) P- SCAD cases.
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Clinical and angiographic presentation
Two hundred and twenty- one blindly selected SCAD- non- PCI 
controls were included for comparison of clinical presentation 
as shown in figure 1 and table 1. SCAD- PCI patients were more 
likely to present with STEMI and with TIMI 0/1 than SCAD- 
non- PCI (figure 1A, table 1). In keeping with this, while Yip- Saw 
classification type 2 SCAD was the most common angiographic 
class at presentation, SCAD- PCI patients were more likely to 
present with Yip- Saw classification type 4 (occlusions) compared 
with SCAD non- PCI patients (table 1, online supplemental 
efigure 1A).
A radial initial approach was undertaken in 74.3% of 
SCAD- PCI patients and in 84.2% of SCAD non- PCI patients. 
The left anterior descending coronary artery was the most 
affected vessel. A coronary heatmap of affected coronary 
segments is shown in figure 1B (a graph of all affected Amer-
ican Heart Association (AHA) coronary segments is shown in 
online supplemental efigure 1B). There was greater involve-
ment of proximal and midvessel lesions in the SCAD- PCI 
compared with the SCAD- non- PCI group (table 1, figure 1C). 
There was more multisegment disease but not multivessel 
disease in SCAD- PCI patients than SCAD- non- PCI patients 
(table 1, figure 1D).
SCAD- PCI lesion characteristics, as assessed by quantitative 
coronary angiography (3D- QCA) are shown in online supple-
mental efigure 2. The median upstream vessel diameter was 
2.7 mm (IQR: 2.3–3.2, n=168) with a downstream diameter 
of 1.8 mm (IQR: 1.5–2.3, n=126) (online supplemental figure 







Total 221 50.7 215 49.3
Age at first SCAD event, years (median, 
IQR)
49 (43–55) 48 (42–54)
Ethnicity*
  White European 212 95.9 197 92.5
  Not white European 9 4.1 16 7.5
Sex
  Female 203 91.9 203 94.4
  Male 18 8.1 12 5.6
Pregnancy status
  Not pregnant (female) 192 86.9 191 88.8
  Pregnant (female) 11 5.0 12 5.6
Smoking
  Never smokers 140 (63.3) 146 (67.9)
  Ex- smokers 55 (24.9) 44 (20.5)
  Current smokers 26 (11.8) 25 (11.6)
Diabetes mellitus
  No >216 (98.2) >210 (99.1)
  Yes <5 (1.8) <5 (0.9)
Hypertension
  No 162 (73.3) 166 (77.2)
  Yes 59 (26.7) 49 (22.8)
Dyslipidaemia
  No 185 (83.7) 187 (87.0)
  Yes 36 (16.3) 28 (13.0)
Clinical characteristics
NSTEMI 131 59.3 74 34.4
STEMI 77 34.8 119 55.3
Cardiac arrest 13 5.9 22 10.2
Left main stem vessel affected <5 2.3 14 6.5
Left anterior descending artery affected 112 50.7 155 72.1
Left circumflex artery affected 83 37.6 48 22.3
Right coronary artery affected 58 26.2 29 13.5
AHA coronary segment involved
  Proximal 17 7.7% 64 29.8%
  Mid 52 23.5% 78 36.3%
  Distal 84 38.0% 45 20.9%
  Branch 68 30.8% 28 13.0%
More than one vessel involved* 32 14.5% 19 8.8%
More than one segment in the vessel 
involved
60 27.1% 83 38.6%
Tortuosity index* (median, IQR) 4 (2-6) 3 (2-5)
Type 1 28 12.7% 26 12.1%
Type 2 153 69.3% 118 54.9%
Type 3 26 11.8% 14 6.5%
Type 4 14 6.3% 57 26.5%
Taking aspirin* 205 94.5% 210 98.1%
Taking DAPT* 161† 74.5% 193† 91.0%
Taking beta- blocker* 173 79.7% 189 88.3%
Taking ACE inhibitors* 146 67.0% 158 73.8%
Taking statins* 155 71.1% 171 80.3%
Intervention quantitative coronary analysis
Type of intervention
  Conservative 221 100.0% – –
  Stent 0 0.0% 156 72.6%






  Wiring 0 0.0% 14 6.5%
Maximum stent diameter, mm (median, 
IQR)
– – 3.0 (2.5–3.5)
Total number of stents (median, IQR) – – 2 (1-3)
Total length of stents, cm (median, IQR) – – 46 (28-61)
Proximal diameter, mm (median, IQR) – – 2.53 (2.15–3.1)
Length of lesion, mm (median, IQR) – – 38.6 (26.6–56.2)
Total volume of haematoma, mm3 
(median, IQR)
– – 57.0 (30.0–
102.7)
Final TIMI grade flow
  0 (no flow) – – 16 7.4%
  1 – – 11 5.1%
  2 – – 23 10.7%
  3 (good flow) – – 165 76.7%
Outcomes
Any complication* – – 83 38.6%
Serious complication* – – 28 13.0%
Time to MACCE (median, IQR) 2.10 (1.06–3.61) 2.32 (1.04–4.28)
MACCE 22 9.5% 31 14.4%
Time to recurrence* (median, IQR) 2.5 (1.2–4.7) 4.4 (2.7–6.3)
Recurrence* 15 6.8% 13 6.1%
*Missing values: ethnicity/race: 2 (0.5%), maximum stent diameter: 74 (34.4%), total 
number of stents: 1 (0.6%), total stent length: 14 (9.0%), proximal diameter: 47 (21.9%), 
lesion length: 74 (34.4%), volume of haematoma: 79 (36.7%), tortuosity index: 1 (0.2%), 
time to recurrence: 2 (0.5%), aspirin: 5 (1.2%), DAPT: 8 (1.8%), beta- blocker: 5 (1.2%), ACE: 
4 (0.9%), statin: 5 (1.2%), recurrence: 2 (0.5%).
†Of those not taking DAPT at discharge, three in the PCI group and two in the non- PCI 
group were anticoagulated. Of those taking DAPT, 65%, 30% and 4% in the non- PCI group 
and 37%, 49% and 14% in the PCI group were taking clopdiogrel, ticagrelor or prasugrel, 
respectively.
DAPT, dual antiplatelet therapy; NSTEMI, non- ST- elevation myocardial infarction; PCI, 
percutaneous coronary intervention; SCAD, spontaneous coronary artery dissection; STEMI, 
ST- elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.
Table 1 Continued
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2A). The median minimal luminal diameter was 0.6 mm (IQR: 
0.4–0.9, n=124), and the median minimal luminal area was 
0.5 mm2 (IQR: 0.3–1.1 mm2, n=121; online supplemental 
efigure 2B). The median of the measured lesion bending 
angles was 47° (IQR: 34–61°, n=148), which was close to 
the maximum bending angle for affected vessels (median 55°; 
IQR: 43–70°, n=168) (online supplemental efigure 2C). The 
median volume of haematoma displaced by stenting was 54.0 
mm3 (IQR: 27.3–113.9 mm3, n=86) (online supplemental 
efigure 2D).
Figure 1 Clinical presentation of SCAD- PCI (n=215) and SCAD- non- PCI patients (n=221), including (A) initial presentation, (B) coronary heatmap of 
affected segments (see also online supplemental efigure 1 for full segment- by- segment analysis), (C) TIMI flow and (D) multisegment and multivessel 
disease. PCI, percutaneous coronary intervention; SCAD, spontaneous coronary artery dissection; TIMI, thrombolysis in myocardial infarction.
Figure 2 Details of the PCI procedure in SCAD intervention patients (n=215): (A) interventional strategy, (B) number of stents deployed, (C) 
stent length compared with lesion length and (D) coronary heat map of stented AHA coronary segments. AHA, American Heart Association; PCI, 
percutaneous coronary intervention; SCAD, spontaneous coronary artery dissection.
1402 Kotecha D, et al. Heart 2021;107:1398–1406. doi:10.1136/heartjnl-2020-318914
Coronary artery disease
Nine patients underwent intracoronary imaging only and 
were included in the SCAD- non- PCI group, 62 patients under-
went intracoronary imaging as part of SCAD- PCI.
Characteristics of SCAD revascularisation
Of patients undergoing PCI, 7.0% (15/215) had failed an initial 
trial of conservative management. Four patients underwent 
emergency CABG, two as a planned revascularisation strategy 
after angiography and two after failed or complicated PCI. The 
nature of the PCI procedure undertaken is shown in figure 2A, 
72.6% (156/215) of patients underwent stenting, mostly with 
drug eluting stents, 20.9% (45/215) had balloon angioplasty, 
5 with cutting balloons and 6.5% (14/215) underwent wiring 
only. The number of stents deployed is shown in figure 2B 
(mean 2.3 (range 1–8) per stented case). Twenty- three cases 
(10.6% of all SCAD- PCI cases) required four or more stents. 
In the 142 patients with both total number of stents and total 
stent length recorded, the median total length of deployed stents 
was 46 mm (IQR: 28.5–60.8 mm; mean 51.5 mm) with 64 
cases (29.8% of all SCAD- PCI cases) requiring ≥50 mm stents 
(figure 2C). 64.1% (100/156) of stented cases were left with 
residual unstented areas of dissection. The median diameter 
of the smallest deployed stent in each case was 2.5 mm (IQR: 
2.5–3.0 mm). Figure 2D shows a coronary heatmap of sites of 
stenting also shown by AHA coronary segment. Areas of residual 
dissection mostly occurred in distal coronary locations such as 
AHA coronary segments, 8, 4, 14 and 16, while initially unaf-
fected segments that were more frequently stented were mainly 
in proximal segments (1, 5 and 11). 10.3% (16/156) of stented 
cases required stenting into the LMS.
Of all SCAD- PCI cases, 33.0% (71/215) required one or more 
of either unplanned LMS stenting, excessive stent number (≥4) 
or stent length (≥50 mm).
Outcomes of SCAD-PCI
Angiographic exemplars of typical complications occurring 
during PCI are shown in figure 3.
The impact of PCI on TIMI flow is shown in figure 4A (with 
findings for the SCAD- STEMI subpopulation shown in online 
supplemental efigure 4A). In those with reduced TIMI flow, 
improvements were seen in 84.3% (118/140) of patients. In all 
patients undergoing PCI, worsening of TIMI flow was seen in 
7.0% (15/215) (figure 4A). Changes in TIMI flow according to 
initial TIMI are shown in online supplemental efigure 3.
Figure 3 Angiographic exemplars of complications (both serious and not serious) occurring during percutaneous coronary intervention. Iatrogenic 
dissection: A1: extensive dissection of mid- right coronary artery (solid arrows) with further haematoma distally (dotted arrow), A2: iatrogenic 
dissection from ostium to mid vessel and A3: extensive stenting from proximal to distal vessel; Haematoma extension: B1: proximal- mid left anterior 
descending haematoma (solid arrows), B2: treated with stenting to the ostium, initially with only small prestent residual haematoma (dotted arrow), 
B3: but later leading to propagation of haematoma into circumflex (solid arrows); Side- branch occlusion: C1: mid- left anterior descending stenosis 
(solid arrows), C2: confirmed on OCT to be due to SCAD and C3: stenting leads to occlusion of diagonal branch (dotted arrow). OCT, optical coherence 
tomography; SCAD, spontaneous coronary artery dissection.
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PCI complications occurred in 38.6% (83/215) of SCAD- PCI 
patients with the the most common being haematoma extension 
(58/215, 27.0%) and iatrogenic dissection (18/215, 8.4%; nine 
occurring during the diagnostic phase and nine after initiation 
of PCI) (figure 4B). Two complications occurred during intra-
coronary imaging, the remainder during SCAD- PCI. A similar 
frequency and distribution of complications was noted in the 
SCAD- STEMI subpopulation (online supplemental efigure 4B). 
Stenting into the false lumen was noted in one case.
Compared with patients without complications, patients who 
developed complications had a longer stent length (median 52 
(IQR: 38–64) PCI complications; median 35 (IQR: 26.8–56) 
PCI no complications; p=0.004). Despite this, 47.0% (39/83) 
showed improvements in TIMI flow grade at procedure end, 
12.0% (10/83) showed a deterioration and 41.0% (34/83) no 
change in TIMI flow grade. Of those with impaired TIMI flow 
grade at the start of the procedure, 33/45 (73.3%) showed an 
improvement in flow in at least one AHA coronary segment 
of a major epicardial coronary territory, while only 5 (11.1%) 
showed a deterioration. Subjectively in terms of overall angio-
graphic coronary perfusion, 44 of 83 (53.0%) cases with 
complications showed an improved situation at procedure end, 
17 (20.5%) showed a deterioration and 22 (26.5%) showed no 
overall change.
13.0 (28/215) of SCAD patients undergoing PCI suffered 
subjectively serious complications (16 cases of iatrogenic dissec-
tion, 16 cases requiring unplanned LMS stenting, 3 cases demon-
strated loss of flow in a proximal AHA coronary segment and 2 
patients required CABG because of PCI failure).
Predictors of any PCI complications and serious compli-
cations are shown in table 2 and online supplemental etable 
1, respectively. Predictors of complications grouped into 
markers of more extensive dissections (lesion length, volume 
of haematoma and multisegment dissections), more prox-
imal dissections (proximal vs distal, proximal diameter and 
maximum stent diameter) and a lack of angiographic contrast 
penetration of the false lumen (Yip- Saw classification type 2). 
Of these multisegment dissections, LMS dissections and the 
use of larger diameter stents remained predictors of serious 
complications.
When all variables associated with the outcome were included 
in the model, along with age, sex and ethnicity, the total number 
of stents remained associated with the risk of any complication 
in SCAD- PCI patients (OR=1.90, 95% CI 1.26 to 2.85), and 
the maximum stent diameter remained associated with risk of 
serious complications in SCAD- PCI patients (OR=2.62, 95% CI 
1.28 to 5.39) (online supplemental etable 2 and 3).
Long-term outcomes
Follow- up information was available on 436 patients 
(median follow- up 900 days, IQR: 440–1590). Most 
patients retained good cardiac ejection fraction at follow- up 
regardless of revascularisation strategy (online supplemental 
efigure 5). There was no difference in MACCE events 
between SCAD- PCI and SCAD- non- PCI patients (online 
supplemental efigure 6A, PCI: 14.4%, 31/215, non- PCI: 
9.5%, 21/221; MACCE components - recurrent AMI (PCI: 
9.3%, 20/215, non- PCI: 7.7%, 17/221); revascularisation 
(PCI: 4.7%, non- PCI: 1.4%); stroke (PCI: 1.5%, non- PCI: 
0.7%); death (PCI: 1.4%, non- PCI: 0.5%)). There was also 
no difference in the incidence of recurrent SCAD between 
the PCI and non- PCI groups (online supplemental efigure 
6B, PCI: 6.1%, 13/214, non- PCI: 6.8%, 15/220).
DISCUSSION
We present the largest international observational study of PCI 
in SCAD. We report first that PCI in current SCAD practice 
is appropriately reserved for more serious clinical and angio-
graphic presentations including STEMI, reduced TIMI flow and 
proximal disease. Second, that complications in SCAD- PCI are 
high, occurring in 38.6% of cases, one- third of which are serious 
(defined as iatrogenic dissection, unplanned LMS stenting, loss 
of flow in proximal AHA coronary segment and emergency 
CABG). Third, that despite the higher rates of complications 
and longer stent lengths required for SCAD- PCI, intervention 
in this context generally resulted in improvements in measures 
of coronary flow. Finally, that measures of more extensive and 
more proximal dissections as well as those without contrast 
penetration into the false lumen are associated with a higher risk 
of complications.
The first important risk of PCI in SCAD is the requirement 
for multiple, often small calibre stents and longer stent lengths. 
SCAD- PCI on average required an extra 0.7 stents and an extra 
21.4 mm of stent compared with UK national audit data (mean 
1.64 stents; 30.1 mm stented length per stented case), where 
atherosclerotic disease will predominate.13 Overall, one- third of 
SCAD- PCI patients required at least one of unplanned LMS PCI, 
≥4 stents or ≥50 mm stent length. Furthermore, despite exten-
sive stenting, there remained unstented dissection in 64.1% of 
SCAD- PCI cases. Despite this, over the duration of available 
MACCE follow- up (median 30 months), there was no overall 
increase in MACCE in the SCAD- PCI group (despite the more 
severe characteristics at presentation). Importantly, longer term 
adverse sequelae of the more extensive stenting in this relatively 
Figure 4 (A) Changes in thrombolysis in myocardial infarction (TIMI) flow for SCAD- PCI patients and (B) PCI complications in the SCAD- PCI cohort 
(n=215). CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; SCAD, spontaneous coronary artery dissection.
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young SCAD population are currently unclear, and further data 
are needed to assess this.
The high rate of complications is another risk of SCAD- PCI, 
which has been widely reported4 5 and is confirmed in this study. 
However, in keeping with a previous study in SCAD- STEMI,14 
most patients undergoing PCI in this study were high risk at 
presentation with only 8.8% undergoing PCI outside the context 
of STEMI/cardiac arrest, TIMI 0/1 flow or proximal dissec-
tions. Conservative management in these patients would likely 
incur higher jeopardy. Furthermore, this analysis confirms that, 
even within this group, complications are more likely to occur 
in patients with more extensive and more proximal dissections, 
where larger volumes of false lumen haematoma pose a greater 
risk from displacement or propagation during stenting. Also of 
potential clinical utility is the finding that angiographic features 
of intramural haematoma without contrast penetration of the 
false lumen (Yip- Saw classification type 2) were more associated 
with complications, suggesting perhaps that connections between 
true and false lumen allow decompression of the false lumen 
with stent inflation, making haematoma propagation and there-
fore PCI complications less likely. Stent number and stent length 
also correlated with PCI complications, but for these factors, it 
is difficult to determine cause versus effect. Coronary tortuosity, 
known to be increased in SCAD,15 did not increase the risk of PCI 
complications.
There were also important benefits of SCAD- PCI. Improve-
ments in TIMI flow grade were seen after PCI in 84.3% of cases 
with 38.6% improving three grades, 23.6% improving two grades 
and 22.1% improving one grade. Only 7.0% of cases saw a dete-
rioration in TIMI flow grade with PCI. Interestingly, these gains 
were mostly seen in cases where stenting rather than more limited 
wiring or plain old balloon angioplasty strategies was adopted.
Taken together these data suggest that PCI should remain 
the reserve of high- risk SCAD presentations. Operators 
Table 2 Association between patient, clinical and intervention characteristics and odds of any complication in a SCAD cohort
Unadjusted Age, sex and ethnicity adjusted
Cases/n OR (95% CI) P value Cases/n OR (95% CI) P value
Patient characteristics
Age at first SCAD event, per year 83/215 1.01 (0.98 to 1.04) 0.631 n/a n/a n/a
Ethnicity (white European vs non- white European)* 83/213 0.81 (0.29 to 2.26) 0.684 n/a n/a n/a
Male versus female 83/215 0.78 (0.23 to 2.69) 0.658 n/a n/a n/a
Pregnant female versus non- pregnant female 79/203 0.50 (0.13 to 1.92) 0.316 79/201 0.51 (0.12 to 2.15) 0.360
Grading of tortuosity for all vessels imaged, per unit* 83/214 0.95 (0.85 to 1.07) 0.437 83/213 0.94 (0.83 to 1.06) 0.349
Clinical characteristics
Type of myocardial infarction
   STEMI versus NSTEMI 83/215 0.92 (0.51 to 1.67) 0.794 83/213 0.91 (0.50 to 1.65) 0.753
   Cardiac arrest versus NSTEMI 0.68 (0.25 to 1.88) 0.462 0.74 (0.27 to 2.08) 0.573
Left main stem vessel affected 83/215 1.64 (0.56 to 4.87) 0.369 83/217 1.67 (0.55 to 5.12) 0.366
Left anterior descending artery affected 83/215 0.92 (0.50 to 1.70) 0.794 83/217 0.90 (0.49 to 1.66) 0.736
Left circumflex artery affected 83/215 1.05 (0.55 to 2.03) 0.874 83/217 1.05 (0.55 to 2.02) 0.879
Right coronary artery affected 83/215 1.14 (0.52 to 2.53) 0.742 83/217 1.18 (0.54 to 2.59) 0.679
AHA coronary segment involved
   Mid versus proximal 83/215 0.79 (0.40 to 1.54) 0.485 83/213 0.74 (0.37 to 1.46) 0.383
   Distal versus proximal 0.32 (0.14 to 0.76) 0.010 0.29 (0.12 to 0.71) 0.007
   Branch versus proximal 0.73 (0.30 to 1.81) 0.501 0.65 (0.26 to 1.66) 0.367
More than one vessel involved 83/215 0.92 (0.35 to 2.44) 0.869 83/213 1.03 (0.38 to 2.78) 0.960
More than one segment within the vessel involved 83/215 1.77 (1.01 to 3.11) 0.046 83/213 1.90 (1.06 to 3.39) 0.030
Yip- Saw classification based on appearance when first imaged
  Type 2 versus type 1 83/215 2.90 (1.13 to 7.42) 0.026 83/213 2.89 (1.12 to 7.43) 0.028
  Type 3 versus type 1 2.71 (0.70 to 10.57) 0.150 2.70 (0.69 to 10.64) 0.155
  Type 4 versus type 1 0.44 (0.14 to 1.39) 0.163 0.42 (0.13 to 1.33) 0.141
Intervention details
Type of intervention
  Balloon versus stent 83/215 0.08 (0.02 to 0.26) <0.001 83/213 0.07 (0.02 to 0.24) <0.001
  Wiring versus stent 0.60 (0.19 to 1.87) 0.379 0.53 (0.17 to 1.68) 0.278
Maximum stent diameter, per mm* 65/141 1.83 (1.04 to 3.25) 0.037 65/140 1.93 (1.06 to 3.49) 0.030
Total number of stents, per additional stent* 74/155 1.39 (1.06 to 1.80) 0.015 74/154 1.48 (1.12 to 1.95) 0.006
Total length of stents, per mm* 66/142 1.01 (1.00 to 1.02) 0.137 66/141 1.01 (1.00 to 1.02) 0.049
Proximal diameter, per mm* 65/168 2.11 (1.32 to 3.37) 0.002 65/166 2.25 (1.38 to 3.67) 0.001
Length of lesion, per mm* 59/141 1.02 (1.00 to 1.03) 0.068 59/139 1.02 (1.00 to 1.03) 0.060
Volume of haematoma, per mm3* 59/136 1.01 (1.00 to 1.01) 0.016 59/135 1.01 (1.00 to 1.01) 0.014
TIMI flow
  1 versus 0 (no flow) 83/215 0.65 (0.14 to 3.04) 0.582 83/213 0.66 (0.14 to 3.10) 0.596
  2 versus 0 (no flow) 0.85 (0.24 to 3.06) 0.802 0.86 (0.24 to 3.12) 0.817
  3 (good flow) versus 0 (no flow) 0.41 (0.15 to 1.16) 0.093 0.42 (0.15 to 1.21) 0.107
Only individuals who underwent stenting were included in analyses of the maximum of stent diameter, the total number of stents and the total stent length.
ARB, angiotensin II receptor blockers; DAPT, dual antiplatelet therapy; NSTEMI, non- ST- elevation myocardial infarction; SCAD, spontaneous coronary artery dissection; STEMI, ST- elevation 
myocardial infarction; TIMI, thrombolysis in myocardial infarction.
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should be aware that the risk of complications is higher 
than for atherosclerotic cases and that long lengths of stent 
may be required. Cases with extensive dissections, prox-
imal dissections and those with no contrast penetration into 
the false lumen may be at particularly high risk. However, 
despite this, it is possible in most of these high- risk cases 
to achieve subjective improvements in coronary perfusion. 
It should be noted that there is also potential to further 
improve the risk–benefit balance in SCAD- PCI by consid-
ering measures to reduce potentially avoidable complica-
tions such as the use of less aggressive more coaxial catheter 
shapes that might reduce the risk of iatrogenic dissection in 
patients with clinically possible SCAD. The point of equi-
poise between PCI and a conservative approach to revascu-
larisation remains unclear. A previous propensity matched 
analysis of angiographically and clinically matched cases 
showed no difference in convalescent infarct size between 
PCI and conservatively managed cases.16 This analysis was 
inevitably largely limited to intermediate risk anatomies. A 
clinical trial in predefined higher risk anatomies is required 
to address this question definitively. It was also not possible 
from this analysis to assess the efficacy of different PCI tech-
niques. Future studies should be designed to investigate this.
Limitations
This is an observational study, and therefore, we cannot conclude 
that the associations demonstrated are causative. Our data are 
derived from a SCAD survivor cohort and do not include infor-
mation on early SCAD- PCI non- survivors. Although the three 
national SCAD registries recruit all comers and include patients 
referred from hospital clinicians, primary care physicians and 
self- referrals, there remains the potential for selection bias. The 
non- PCI cohort were selected blinded to clinical and angiographic 
findings. The difference in cohort sizes is due to a small number 
of exclusions arising after case selection. Exclusions arose when a 
case was felt by any observer not to be definite SCAD on review of 
angiography (plus intracoronary imaging when present) during the 
analysis phase. Criteria for both complications and serious compli-
cations were selected by experienced SCAD interventional cardiol-
ogists but are not established definitions. Benchmarking data from 
the BCIS audit are discussed to allow a meaningful comparison of 
stenting data. These data are from a single national jurisdiction, 
although no significant transnational differences were observed 
online supplemental etable 4. Data on cardiogenic shock were not 
available, although the reported incidence in larger SCAD series is 
low (2%17).
CONCLUSIONS
While a conservative approach to revascularisation in SCAD 
is optimal where possible, sometimes the clinical presentation 
(STEMI, cardiac arrest, poor TIMI flow and proximal occlusive 
dissection) mandates intervention to improve coronary perfu-
sion and reduce myocardial injury. This study demonstrates 
that although more extensive stenting may be required, with an 
elevated risk of procedural complications, improved coronary flow 
and good medium- term outcomes can be achieved with PCI. More 
extensive dissection, proximal segment location and an absence of 
contrast penetration of the false lumen associate with the highest 
risk of PCI complications.
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Key messages
What is already known on this subject?
 ► Percutaneous coronary intervention (PCI) in spontaneous 
coronary artery dissection (SCAD) is associated with high 
rates of procedural complications.
 ► A conservative approach to revascularisation is recommended 
where possible.
What might this study add?
 ► The ‘cost’ of PCI in SCAD is longer stent lengths and more 
procedural complications.
 ► The ‘benefit’ of PCI in SCAD is improved coronary flow.
 ► Outcomes from SCAD- PCI in terms of left ventricular function 
and major adverse cardiovascular and cerebrovascular events 
are generally good.
How might this impact on clinical practice?
 ► Case selection for PCI in SCAD is critical. Most cases can be 
managed conservatively but for high- risk cases (eg, proximal 
to mid vessel occlusions) intervention is required.
 ► While PCI is associated with a significant risk of procedural 
complications requiring long stent lengths, improved flow 
and good long- term outcomes can be achieved.
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